HALO
NASDAQStockHalozyme Therapeutics, Inc.
$63.98-2.52 (-3.78%)
52-Week Range
$47.91
$81.23
Key Stats
Market Cap
7.6B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.02
Volume
1.2M
Avg Volume
1.7M
Performance
1M
-20.06%
3M
+0.17%
6M
-16.73%
YTD
-9.60%
1Y
+4.09%
3Y
+51.33%
5Y
+45.88%
Price Chart
ETF Exposure
HALO is held by 190 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| RECS | Columbia Research Enhanced Core ETF | 0.01% |
| SPTM | State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.01% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.01% |
| IWB | iShares Russell 1000 ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| IYY | iShares Dow Jones U.S. ETF | 0.01% |
| SCHK | Schwab 1000 Index ETF | 0.01% |
| VONE | Vanguard Russell 1000 ETF | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.01% |
| VT | Vanguard Total World Stock ETF | 0.01% |
| VLU | State Street SPDR S&P 1500 Value Tilt ETF | 0.01% |
| FNDB | Schwab Fundamental U.S. Broad Market Index ETF | 0.01% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| IALT | iShares Systematic Alternatives Active ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.00% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 0.00% |
| LRND | NYLI U.S. Large Cap R&D Leaders ETF | 0.00% |
| THRO | iShares U.S. Thematic Rotation Active ETF | 0.00% |
PreviousPage 4 of 4
About HALO ETF Exposure
Halozyme Therapeutics, Inc. (HALO) is held by 190 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.6B, HALO is a widely held institutional stock. The stock currently trades at $63.98. Investors can gain exposure to HALO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HALO, sorted by portfolio weight.